Literature DB >> 24656590

Intratendinous injection of platelet-rich plasma under US guidance to treat tendinopathy: a long-term pilot study.

Benjamin Dallaudière1, Lionel Pesquer2, Philippe Meyer2, Alain Silvestre2, Anne Perozziello3, Alain Peuchant2, Marie Hélène Moreau Durieux2, Philippe Loriaut4, Vincent Hummel5, Patrick Boyer4, Elisabeth Schouman-Claeys6, Jean Michel Serfaty7.   

Abstract

PURPOSE: To assess the potential therapeutic effect of intratendinous injection of platelet-rich plasma (PRP) under ultrasound (US) guidance to treat tendon tears and tendinosis in a pilot study with long-term follow-up.
MATERIALS AND METHODS: The study included 408 consecutive patients referred for treatment by PRP injection of tendinopathy in the upper (medial and lateral epicondylar tendons) and the lower (patellar, Achilles, hamstring and adductor longus, and peroneal tendons) limb who received a single intratendinous injection of PRP under US guidance. Clinical and US data were retrospectively collected for each anatomic compartment for upper and lower limbs before treatment (baseline) and 6 weeks after treatment. Late clinical data without US were collected until 32 months after the procedure (mean, 20.2 months). The McNemar test and regression model were used to compare clinical and US data.
RESULTS: QuickDASH score, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score, and residual US size of lesions were significantly lower after intratendinous injection of PRP under US guidance at 6 weeks and during long-term follow-up compared with baseline (P < .001 in upper and lower limb) independent of age, gender, and type of tendinopathy (P > .29). No clinical complication was reported during follow-up.
CONCLUSIONS: Intratendinous injection of PRP under US guidance appears to allow rapid tendon healing and is well tolerated.
Copyright © 2014 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24656590     DOI: 10.1016/j.jvir.2014.01.026

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  17 in total

1.  Intratendinous adipose-derived stromal vascular fraction (SVF) injection provides a safe, efficacious treatment for Achilles tendinopathy: results of a randomized controlled clinical trial at a 6-month follow-up.

Authors:  Federico Giuseppe Usuelli; Miriam Grassi; Camilla Maccario; Marco Vigano'; Luciano Lanfranchi; Umberto Alfieri Montrasio; Laura de Girolamo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-03-01       Impact factor: 4.342

Review 2.  The use of platelet-rich plasma to augment conservative and surgical treatment of hip and pelvic disorders.

Authors:  Matthew J Kraeutler; Tigran Garabekyan; Omer Mei-Dan
Journal:  Muscles Ligaments Tendons J       Date:  2016-12-21

Review 3.  Myths and Facts of In-Office Regenerative Procedures for Tendinopathy.

Authors:  Alyssa Neph; Kentaro Onishi; James H-C Wang
Journal:  Am J Phys Med Rehabil       Date:  2019-06       Impact factor: 2.159

Review 4.  Conservative management of tendinopathies around hip.

Authors:  Antonio Frizziero; Filippo Vittadini; Andrea Pignataro; Giuseppe Gasparre; Carlo Biz; Pietro Ruggieri; Stefano Masiero
Journal:  Muscles Ligaments Tendons J       Date:  2016-12-21

5.  Efficacy of autologous leukocyte-reduced platelet-rich plasma therapy for patellar tendinopathy in a rat treadmill model.

Authors:  Mamoru Yoshida; Hiroki Funasaki; Keishi Marumo
Journal:  Muscles Ligaments Tendons J       Date:  2016-09-17

Review 6.  Platelet-rich plasma: evidence for the treatment of patellar and Achilles tendinopathy--a systematic review.

Authors:  B Di Matteo; G Filardo; E Kon; M Marcacci
Journal:  Musculoskelet Surg       Date:  2014-10-17

Review 7.  Platelet-rich plasma in tendon-related disorders: results and indications.

Authors:  Giuseppe Filardo; Berardo Di Matteo; Elizaveta Kon; Giulia Merli; Maurilio Marcacci
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-09-24       Impact factor: 4.342

8.  The molecular systemic and local effects of intra-tendinous injection of Platelet Rich Plasma in tendinosis: preliminary results on a rat model with ELISA method.

Authors:  Benjamin Dallaudiere; Liliane Louedec; Marie Paule Jacob Lenet; Lionel Pesquer; Elvind Blaise; Anne Perozziello; Jean Baptiste Michel; Maryse Moinard; Philippe Meyer; Jean Michel Serfaty
Journal:  Muscles Ligaments Tendons J       Date:  2015-07-03

9.  Infiltration of Autologous Growth Factors in Chronic Tendinopathies.

Authors:  Antonio Crescibene; Marcello Napolitano; Raffaella Sbano; Enrico Costabile; Hesham Almolla
Journal:  J Blood Transfus       Date:  2015-06-15

Review 10.  Clinical applications of platelet-rich plasma in patellar tendinopathy.

Authors:  D U Jeong; C-R Lee; J H Lee; J Pak; L-W Kang; B C Jeong; S H Lee
Journal:  Biomed Res Int       Date:  2014-07-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.